Jennison Associates Portfolio holdings
Jennison Associates, founded in 1969 and headquartered in New York City, is a global investment management firm managing over $194 billion in assets as of late 2024, specializing in active equity and fixed-income strategies. A subsidiary of PGIM, the asset management arm of Prudential Financial, Jennison serves a diverse client base—including institutions, sub-advisory clients, public plans, endowments, and corporations—with a focus on fundamental research, bottom-up portfolio construction, and high-conviction investing. Known for its equity expertise across styles, geographies, and market capitalizations, as well as investment-grade fixed-income offerings, the firm employs seasoned portfolio managers averaging 29 years of industry experience and 16 years with Jennison. With additional offices in Boston and a culture emphasizing intellectual rigor and long-term client outcomes, Jennison has built a reputation for excellence and stability in the investment management industry.
Top Buys
| 1 |
PayPal
PYPL
|
+$650M |
| 2 |
Home Depot
HD
|
+$617M |
| 3 |
Costco
COST
|
+$570M |
| 4 |
Caterpillar
CAT
|
+$524M |
| 5 |
AbbVie
ABBV
|
+$506M |
Top Sells
| 1 |
NVIDIA
NVDA
|
+$757M |
| 2 |
Booking.com
BKNG
|
+$555M |
| 3 |
CELG
Celgene Corp
CELG
|
+$537M |
| 4 |
Crown Castle
CCI
|
+$509M |
| 5 |
Regeneron Pharmaceuticals
REGN
|
+$423M |
Sector Composition
| 1 | Technology | 20.86% |
| 2 | Consumer Discretionary | 15.65% |
| 3 | Financials | 12.8% |
| 4 | Healthcare | 12.57% |
| 5 | Communication Services | 11.95% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
426
Wheaton Precious Metals
WPM
$47.6B
| $15.9M | 0.02% |
719,931
-35,138
| -5% | -$778K |
|
427
Independence Realty Trust
IRT
$4.13B
| $15.9M | 0.02% |
1,573,435
+323,435
| +26% | +$3.26M |
|
428
Monolithic Power Systems
MPWR
$41.2B
| $15.7M | 0.02% |
140,051
-653
| -0.5% | -$73.4K |
|
429
Philips
PHG
$26.9B
| $15.7M | 0.02% |
526,759
+197,108
| +60% | +$5.87M |
|
430
Chemours
CC
$2.47B
| $15.6M | 0.02% |
312,491
-131,572
| -30% | -$6.59M |
|
431
Kinder Morgan
KMI
$60.2B
| $15.6M | 0.02% |
865,138
-2,034,264
| -70% | -$36.8M |
|
432
Prothena Corp
PRTA
$451M
| $15.6M | 0.02% |
416,031
+5,313
| +1% | +$199K |
|
433
General Dynamics
GD
$86.7B
| $15.3M | 0.02% |
75,147
-105,030
| -58% | -$21.4M |
|
434
BioCryst Pharmaceuticals
BCRX
$1.69B
| $15.1M | 0.01% |
3,082,235
+5,774
| +0.2% | +$28.4K |
|
435
Nektar Therapeutics
NKTR
$929M
| $15.1M | 0.01% |
+16,894
| New | +$15.1M |
|
436
Universal Display
OLED
$6.5B
| $14.9M | 0.01% |
+86,450
| New | +$14.9M |
|
437
Guidewire Software
GWRE
$21.2B
| $14.7M | 0.01% |
197,889
-79,246
| -29% | -$5.88M |
|
|
ANDX
438
DELISTED
Andeavor Logistics LP
ANDX
| $14.7M | 0.01% |
+317,602
| New | +$14.7M |
|
439
B&G Foods
BGS
$363M
| $14.5M | 0.01% |
412,973
+174,111
| +73% | +$6.12M |
|
440
Energy Transfer Partners
ET
$59.7B
| $14.3M | 0.01% |
825,652
-19,042
| -2% | -$329K |
|
|
NBLX
441
DELISTED
Noble Midstream Partners LP
NBLX
| $14.1M | 0.01% |
282,468
-18,428
| -6% | -$921K |
|
442
MGP Ingredients
MGPI
$589M
| $13.8M | 0.01% |
179,041
-414
| -0.2% | -$31.8K |
|
|
BPMC
443
DELISTED
Blueprint Medicines
BPMC
| $13.6M | 0.01% |
180,085
-48,532
| -21% | -$3.66M |
|
444
Eastman Chemical
EMN
$7.65B
| $13.4M | 0.01% |
144,277
-10,908
| -7% | -$1.01M |
|
445
Apellis Pharmaceuticals
APLS
$3.32B
| $13.2M | 0.01% |
+606,925
| New | +$13.2M |
|
446
FibroGen
FGEN
$46.5M
| $13.1M | 0.01% |
11,077
+2,077
| +23% | +$2.46M |
|
447
Amgen
AMGN
$149B
| $12.9M | 0.01% |
74,421
-115,330
| -61% | -$20.1M |
|
448
Antero Midstream
AM
$8.76B
| $12.8M | 0.01% |
647,789
-232,370
| -26% | -$4.58M |
|
|
AM
449
DELISTED
ANTERO MIDSTREAM PARTNERS LP
AM
| $12.7M | 0.01% |
438,393
-75,852
| -15% | -$2.2M |
|
|
BPL
450
DELISTED
Buckeye Partners, L.P.
BPL
| $12.7M | 0.01% |
256,640
-40,515
| -14% | -$2.01M |
|